Predicting risk of adverse drug reactions in older adults

Therapeutic Advances in Drug Safety
Amanda Hanora Lavan, Paul Gallagher

Abstract

Adverse drug reactions (ADRs) are common in older adults, with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding being amongst the most common clinical manifestations. ADR risk increases with age-related changes in pharmacokinetics and pharmacodynamics, increasing burden of comorbidity, polypharmacy, inappropriate prescribing and suboptimal monitoring of drugs. ADRs are a preventable cause of harm to patients and an unnecessary waste of healthcare resources. Several ADR risk tools exist but none has sufficient predictive value for clinical practice. Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation. New medications should be prescribed cautiously with clear therapeutic goals and recognition of the impact a drug can have on multiple organ systems. Prescribers should regularly review medication efficacy and be vigilant for ADRs and their contributory risk factors. Deprescribing should occur at an individual level when drugs are no longer efficacious or beneficial or when safer alternatives exist. Inappropriat...Continue Reading

References

Aug 17, 1979·JAMA : the Journal of the American Medical Association·M S KramerA R Feinstein
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Jul 27, 1994·JAMA : the Journal of the American Medical Association·S M WillcoxS Woolhandler
Feb 1, 1996·Journal of the American Geriatrics Society·J W Cooper
Sep 1, 1996·The American Journal of Emergency Medicine·R M GoldbergS Wong
Jan 1, 1997·Ryōikibetsu shōkōgun shirīzu·K Kubo, M Kato
Aug 1, 1997·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·I Verhaeverbeke, T Mets
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V A Maria, R M Victorino
Nov 21, 1997·BMJ : British Medical Journal·P A Rochon, J H Gurwitz
Apr 29, 1998·JAMA : the Journal of the American Medical Association·J LazarouP N Corey
Dec 12, 1983·Drug Information Journal·B E Wiholm
May 12, 2000·Journal of the American College of Cardiology·J S GottdienerR C Boineau
Nov 10, 2000·Lancet·I R Edwards, J K Aronson
Nov 23, 2000·Lancet·U A Meyer
Jul 18, 2001·Internal Medicine Journal·M ChanJ H Vial
Jan 5, 2002·American Journal of Clinical Dermatology·M Rademaker
Jun 14, 2002·Pharmacy World & Science : PWS·H J M Beijer, C J de Blaey
Dec 18, 2003·British Journal of Clinical Pharmacology·A A Mangoni, S H D Jackson
Mar 10, 2004·The American Journal of Medicine·Kenneth E SchmaderHarvey Jay Cohen
May 19, 2004·Annals of Internal Medicine·Jonathan R NebekerMatthew H Samore
Jul 3, 2004·BMJ : British Medical Journal·Munir PirmohamedAlasdair M Breckenridge
Nov 24, 2004·The American Journal of Geriatric Pharmacotherapy·Emily R HajjarKenneth E Schmader
Jun 29, 2006·British Journal of Clinical Pharmacology·R L HowardM Pirmohamed
Aug 31, 2006·British Journal of Clinical Pharmacology·Kirsten K ViktilAasmund Reikvam
Mar 29, 2007·The Annals of Pharmacotherapy·John R HornLingtak-Neander Chan
Nov 1, 2007·Nature Reviews. Drug Discovery·Russell A WilkeRonald M Krauss
Jan 9, 2008·The American Journal of Geriatric Pharmacotherapy·Emily R HajjarJoseph T Hanlon
Jun 27, 2008·Journal of the American Medical Informatics Association : JAMIA·Elske AmmenwerthUwe Siebert
Jul 3, 2008·The Annals of Pharmacotherapy·Chuenjid KongkaewDarren M Ashcroft
Feb 25, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Wilbert S Aronow
Feb 23, 2010·Sleep Medicine Reviews·Monique A J MetsJoris C Verster
Apr 20, 2010·Maturitas·Hilary Anne Wynne, Julia Blagburn
Jun 25, 2010·British Journal of Clinical Pharmacology·Hideki ShutoTakashi Yanagawa
Oct 12, 2010·Aging Clinical and Experimental Research·Christophe E GrafThierry Chevalley
Mar 16, 2011·Journal of Biomedicine & Biotechnology·Offie P SoldinDonald R Mattison
Nov 19, 2011·Journal of the American Geriatrics Society·A Clara Drenth-van MaanenRob J van Marum

❮ Previous
Next ❯

Citations

Feb 24, 2018·The Annals of Pharmacotherapy·Ovadyah Avraham, Michael Biglow
Mar 8, 2018·Current Oncology Reports·Kah Poh LohErika Ramsdale
Nov 8, 2017·Drugs -- Real World Outcomes·Natali JokanovicJ Simon Bell
Feb 12, 2017·British Journal of Nursing : BJN·Caroline Kavanagh
Jul 15, 2018·British Journal of Clinical Pharmacology·Stefanie ThevelinOlivia Dalleur
Oct 3, 2018·Pharmacy : Journal of Pharmacy, Education and Practice·Siraj SundaranMohammed Saji Salahudeen
Oct 10, 2018·Journal of the American Geriatrics Society·Catherine A AmmermanTara N Downs
Oct 10, 2018·Age and Ageing·Emma JenningsDenis O'Mahony
Jan 31, 2019·The Journal of Antimicrobial Chemotherapy·Paul Le TurnierUNKNOWN High-Dose Ceftriaxone CNS Infections Study Group
Mar 23, 2019·International Journal of Nursing Knowledge·Vanessa Monteiro MantovaniEneida Rejane Rabelo-Silva
Aug 7, 2017·International Psychogeriatrics·D WuchererW Hoffmann
Apr 3, 2019·Clinical Pharmacology and Therapeutics·Anukriti SharmaJack A Gilbert
Jul 10, 2019·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Yoonmee JooMargaret I Wallhagen
Nov 26, 2019·Journal of the American Geriatrics Society·Stacy Cooper BaileyMichael S Wolf
Jan 28, 2020·Journal of Clinical Pharmacy and Therapeutics·Takayuki MabuchiMitsutaka Takada
Nov 16, 2019·Drug and Therapeutics Bulletin·James A Cave
Aug 21, 2019·Aging Clinical and Experimental Research·Gianluca SferrazzaPasquale Pierimarchi
Sep 29, 2020·Expert Review of Clinical Pharmacology·Matteo Cesari
Oct 1, 2020·Age and Ageing·Roy L Soiza
Nov 25, 2017·International Journal of Clinical Pharmacy·Anne-Laure SennesaelAnne Spinewine
Feb 26, 2019·Therapeutic Advances in Drug Safety·Denis CurtinDenis O'Mahony
Nov 15, 2019·Nature Communications·Michael CalderaJörg Menche
Feb 7, 2017·Heart Failure Reviews·Feras BaderMohammed E Khalil
Jan 1, 2016·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·Sebastian Porsdam MannBarbara J Sahakian
Apr 14, 2017·Aging Clinical and Experimental Research·Giulia ScondottoAlessandra Casuccio
Apr 11, 2019·Current Clinical Pharmacology·Arduino A MangoniElzbieta A Jarmuzewska
Jun 8, 2017·BMC Family Practice·Mariam Molokhia, Azeem Majeed
Jun 28, 2018·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rike van EekerenLinda Härmark
Feb 7, 2020·European Journal of Clinical Pharmacology·Irina DumitrescuTinne Dilles

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
genotyping
pharmacotherapy

Software Mentioned

Structured History - taking of Medication ( SHiM )

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Australian Family Physician
David G Le CouteurRobert G Cumming
American Family Physician
Richard W PretoriusJohn R Miller
© 2021 Meta ULC. All rights reserved